This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Academisch Ziekenhuis Leiden (h.o.d.n. Lumc), Scintomics Gmbh, Technical University of Munich. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 43 
1 out of 1 
1 out of 152 
Years Active: 2025
Title: Fijs W B Van Leeuwen: Innovator in Cancer Imaging and Treatment
Introduction
Fijs W B Van Leeuwen is a notable inventor based in Leiden, Netherlands. He has made significant contributions to the field of cancer imaging and treatment through his innovative research and development.
Latest Patents
Van Leeuwen holds a patent for "Hybrid tracers for targeted cancer imaging and treatment." This invention relates to compounds of formula I or Ia, where Y is EuK, —EuAF, —EuPG, or -L-EuE, and Z is a chelating moiety. The patent also includes formulations comprising such a compound, as well as methods for imaging or treating cancer using these compounds or formulations.
Career Highlights
Throughout his career, Fijs W B Van Leeuwen has worked with prestigious institutions, including Academisch Ziekenhuis Leiden, known as LUMC, and Scintomics GmbH. His work has focused on advancing medical technologies that enhance cancer diagnosis and treatment.
Collaborations
Some of his notable coworkers include Hans-Jurgen Wester and Tessa Buckle, who have collaborated with him on various projects related to his research.
Conclusion
Fijs W B Van Leeuwen's contributions to cancer imaging and treatment through his innovative patents and collaborations highlight his importance in the field of medical research. His work continues to influence advancements in cancer therapies and diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile